These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8738770)

  • 41. Caffeine Administration to Prevent Apnea in Very Premature Infants.
    Armanian AM; Iranpour R; Faghihian E; Salehimehr N
    Pediatr Neonatol; 2016 Oct; 57(5):408-412. PubMed ID: 26976495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Winckworth LC; Powell E
    Arch Dis Child; 2010 Sep; 95(9):757-9. PubMed ID: 20716677
    [No Abstract]   [Full Text] [Related]  

  • 44. Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy.
    Dobson NR; Liu X; Rhein LM; Darnall RA; Corwin MJ; McEntire BL; Ward RM; James LP; Sherwin CM; Heeren TC; Hunt CE
    Br J Clin Pharmacol; 2016 Sep; 82(3):754-61. PubMed ID: 27145974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DBS-LC-MS/MS assay for caffeine: validation and neonatal application.
    Bruschettini M; Barco S; Romantsik O; Risso F; Gennai I; Chinea B; Ramenghi LA; Tripodi G; Cangemi G
    Bioanalysis; 2016 Sep; 8(18):1893-902. PubMed ID: 27532249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
    Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?
    Natarajan G; Botica ML; Thomas R; Aranda JV
    Pediatrics; 2007 May; 119(5):936-40. PubMed ID: 17473094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].
    Alix D; Berthou F; Riche C; Gouedard H
    Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caffeine for apnea of prematurity.
    Coulter DM
    N Engl J Med; 2006 Aug; 355(9):958-9; author reply 959-60. PubMed ID: 16943412
    [No Abstract]   [Full Text] [Related]  

  • 50. Archimedes: Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Schmidt B; Roberts RS; Davis P; Doyle LW;
    Arch Dis Child; 2011 Aug; 96(8):784. PubMed ID: 21377992
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of caffeine compared with theophylline in the treatment of idiopathic apnea in premature infants.
    Fuglsang G; Nielsen K; Kjaer Nielsen L; Sennels F; Jakobsen P; Thelle T
    Acta Paediatr Scand; 1989 Sep; 78(5):786-8. PubMed ID: 2688355
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of caffeine for the treatment of apnea of prematurity and bradycardia in a holoprosencephalic child with cleft lip and palate.
    Kumar M; Chawla R; Haloi P; Singh M
    J Clin Anesth; 2013 Dec; 25(8):678-9. PubMed ID: 24100116
    [No Abstract]   [Full Text] [Related]  

  • 53. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
    Schmidt B; Anderson PJ; Doyle LW; Dewey D; Grunau RE; Asztalos EV; Davis PG; Tin W; Moddemann D; Solimano A; Ohlsson A; Barrington KJ; Roberts RS;
    JAMA; 2012 Jan; 307(3):275-82. PubMed ID: 22253394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous quantitation of serum caffeine and its metabolites by ultra-high-performance liquid chromatography-tandem mass spectrometry for CYP1A2 activity prediction in premature infants.
    Jiang Z; Gao X; Liang J; Ni S
    Biomed Chromatogr; 2021 Sep; 35(9):e5141. PubMed ID: 34041763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
    Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
    Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age.
    Marcus CL; Meltzer LJ; Roberts RS; Traylor J; Dix J; D'ilario J; Asztalos E; Opie G; Doyle LW; Biggs SN; Nixon GM; Narang I; Bhattacharjee R; Davey M; Horne RS; Cheshire M; Gibbons J; Costantini L; Bradford R; Schmidt B;
    Am J Respir Crit Care Med; 2014 Oct; 190(7):791-9. PubMed ID: 25171195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Theophylline or caffeine: which is best for apnea of prematurity?
    Gannon BA
    Neonatal Netw; 2000 Dec; 19(8):33-6. PubMed ID: 11949272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the caffeination of prematurity.
    Stevenson DK
    N Engl J Med; 2007 Nov; 357(19):1967-8. PubMed ID: 17989390
    [No Abstract]   [Full Text] [Related]  

  • 59. Methylxanthines in serum, saliva, and spinal fluid of premature infants.
    Somani SM; Khanna NN
    Semin Perinatol; 1981 Oct; 5(4):346-50. PubMed ID: 7302610
    [No Abstract]   [Full Text] [Related]  

  • 60. [The choice between theophylline and caffeine in the treatment of apnea in premature infants].
    Bairam A; Boutroy MJ; Badonnel Y; Vert P
    Arch Fr Pediatr; 1990; 47(6):461-5. PubMed ID: 2206108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.